Public Health Agency of Canada

This biosafety directive is intended to provide a comprehensive overview of the risk assessment outcomes, subsequent containment level decisions, and considerations that have been made for those working with MTBC. It describes the activities and MTBC sample types that can be handled at CL2 with...

Health Promotion and Chronic Disease Prevention in Canada: Research, Policy and Practice(the HPCDP Journal) is the monthly, online scientific journal of the Health Promotion and Chronic Disease Prevention Branch of the Public Health Agency of Canada.The journal publishes articles on disease...

The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases. 

This guideline describes the general recommendations and considerations for basic laboratory design and the safe handling of RG1 biological material; these recommended practices are risk-and evidence-based. The physical design features and operational practices for CL1 zones described in this...

"The Canadian Biosafety Guidelines have been developed by the Public Health Agency of Canada (PHAC) and the Canadian Food Inspection Agency (CFIA) as an ongoing series of biosafety and biosecurity themed guidance documents. In Canada, most facilities where human and terrestrial animal pathogens...

In Canada, facilities where Risk Group 2, 3, and 4 human pathogens or toxins are handled and stored are regulated by the Public Health Agency of Canada (PHAC) under the Human Pathogens and Toxins Act (HPTA) and the Human Pathogens and Toxins Regulations (HPTR). The importation of animal...

In Canada, facilities where Risk Group 2, 3, and 4 human pathogens or toxins are handled and stored are regulated by the Public Health Agency of Canada (PHAC) under the Human Pathogens and Toxins Act (HPTA) and the Human Pathogens and Toxins Regulations (HPTR). The importation of animal...

"In Canada, facilities that handle or store Risk Group 2 (RG2), RG3, and RG4 human pathogens or toxins are regulated by the Public Health Agency of Canada (PHAC) under the Human Pathogens and Toxins Act (HPTA) and the Human Pathogens and Toxins Regulations (HPTR). The importation of animal...

The biosafety handbook on safe and secure handling of pathogens and toxins in Canada.

This Guideline provides comprehensive guidance on how to complete and submit a notification report and, where exposure or laboratory acquired infections/intoxications (LAIs) is concerned, a subsequent follow-up report to the Public Health Agency of Canada in accordance with requirements in the...

The Local Risk Assessment guideline describes best practices for conducting a local risk assessment (LRA) in an organization where human or animal pathogens, toxins, or other regulated infectious material are handled or stored.

The human immunodeficiency virus (HIV) and the human T-cell lymphotropic virus type 1 (HTLV-1) are examples of RG3 pathogens where the pathogen risk and CL assessments have been revisited by the Agency in conjunction with HIV/HTLV specialists based on current risks associated with activities...

This guideline describes best practices for conducting a biosecurity risk assessment in an organization where human or animal pathogens, toxins, or other regulated infectious material are handled or stored. The biosecurity risks associated with the handling and storing of pathogens and toxins can...

Canada’s Canadian Biosafety Standard (CBS), 2nd Edition, 2015, is a harmonized national standard for the handling or storing of human and terrestrial animal pathogens and toxins in Canada.

Weekly surveillance reports and monitoring maps for measles and rubella in Canada. As a nationally reportable disease in Canada, surveillance of measles is conducted by public health professionals in provinces and territories. They report cases to the Government of Canada (GC) through systems at...

Weekly surveillance reports and monitoring maps for measles and rubella in Canada. As a nationally reportable disease in Canada, surveillance of measles is conducted by public health professionals in provinces and territories. They report cases to the Government of Canada (GC) through systems at...

Weekly surveillance reports and monitoring maps for measles and rubella in Canada. As a nationally reportable disease in Canada, surveillance of measles is conducted by public health professionals in provinces and territories. They report cases to the Government of Canada (GC) through systems at...

Weekly surveillance reports and monitoring maps for measles and rubella in Canada. As a nationally reportable disease in Canada, surveillance of measles is conducted by public health professionals in provinces and territories. They report cases to the Government of Canada (GC) through systems at...

Weekly surveillance reports and monitoring maps for measles and rubella in Canada. As a nationally reportable disease in Canada, surveillance of measles is conducted by public health professionals in provinces and territories. They report cases to the Government of Canada (GC) through systems at...

The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases.